Andy Walker

Andy Walker is a chemical engineer turned biotech operator who co-founded GentiBio, a Cambridge-based company engineering regulatory T cells (EngTregs) to functionally cure autoimmune and autoinflammatory diseases. He started as the company's CTO, moved through President and COO, and became President and CEO in 2024. Before GentiBio he ran manufacturing for cell and protein therapeutics at Juno Therapeutics and led Jewel Biotherapeutics. He holds a PhD in chemical engineering from UC Berkeley and a BS from the University of Washington.